Bionik Laboratories Corp. Quarterly Operating Margin in % from Q1 2021 to Q1 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Bionik Laboratories Corp. quarterly/annual Operating Margin history and growth rate from Q1 2021 to Q1 2023.
  • Bionik Laboratories Corp. Operating Margin for the quarter ending March 31, 2023 was -267 %, a 65.9% increase year-over-year.
  • Bionik Laboratories Corp. annual Operating Margin for 2013 was -27.9K %, a 123% decline from 2012.
  • Bionik Laboratories Corp. annual Operating Margin for 2012 was -12.5K %, a 19426% decline from 2011.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 -267 +516 +65.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -330 +288 +46.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -962 -205 -27% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.25K -489 -64.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -783 +335 +29.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -617 Oct 1, 2021 Dec 31, 2021
Q3 2021 -757 Jul 1, 2021 Sep 30, 2021
Q2 2021 -758 Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.12K Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.